Director, Medical Writing
Dyne Therapeutics · Remote · location not stated
$190k–$235k/yr
Lyell ImmunopharmaUnited States10+ years experience
$220k–$240k/yr listed by the employer
On Lyell Immunopharma’s own careers site (Greenhouse), checked open today.
Summarised from the posting by AI and can be wrong. The full description is the source.
Sign in and add your resume to see which of this job's requirements it shows.
Sign in to check your matchSaved to your account, encrypted. The AI that reads it doesn't keep it or train on it.
From Lyell Immunopharma’s careers site
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. And for patients with hematologic malignancies, there is a need for next-generation cell therapies that can deliver increased response rates and longer duration of response. We are a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. Lyell’s product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to advance next-generation CAR T-cell therapies, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency.
We are seeking a Director of Medical Writing to build Lyell’s medical writing capability; initially operating as author and independent owner of our clinical regulatory documents, with long term responsibility for building out the function as we advance our cell therapy portfolio through BLA submission and into commercial launch.
Reporting to the VP of Regulatory Affairs, this individual will partner with Regulatory and Clinical Development providing responsive, available, and action-focused support, able to turn a design discussion into draft text quickly. Recurring deliverables are protocols, protocol amendments, Investigator’s Brochures, and clinical study reports, which move on clinical timelines and cannot slip. In parallel, you will author Module 2 clinical summary content as the submission takes shape.
This is a player-coach role in a lean organization. You will own vendor management and medical writing infrastructure while personally authoring priority documents, with the internal-versus-outsourced split refined as the program matures. Contribution on CMC technical writing or health authority briefing documents is a differentiator, not an entry requirement.
Key Responsibilities
Clinical Document Ownership — Core of the Role
Module 2 Authoring
Vendor and Resource Management
Process and Infrastructure
AI-Enabled Authoring and Efficiency
Additional Scope — Valued, Not Required
Qualifications
Required
Preferred
The salary range for this position is $220,000 to $240,000, annually, with the opportunity to earn an annual bonus. The salary range is an estimate, and the actual salary may vary based on Lyell’s compensation practices and an applicant’s qualifications and experience. Employees are also eligible to participate in Lyell’s Equity Incentive Plan.
At Lyell, we believe that highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse and inclusive culture for all employees. Lyell is proud to be an equal opportunity employer and does not discriminate on the basis of race, color, citizenship status, national origin, ancestry, sex, sexual orientation, age, religion, creed, physical or mental disability, medical condition, marital status, veteran status or any other characteristics protected under applicable federal, state and local laws.
Something wrong with this job? Report it · This flag looks wrong

Dyne Therapeutics · Remote · location not stated
$190k–$235k/yr
StrongChecked open todayPosted 18 days ago
Kiniksa Pharmaceuticals · Lexington, MA
$225k–$239k/yrOn-site
StrongChecked open todayPosted 1 month ago

Beeline Medicines · United States
$199k–$258k/yrHybrid
StrongOpen 2 monthsChecked open todayPosted 2 months ago

Corcept Therapeutics · Redwood City, CA
$184k–$243k/yrFull-time
StrongOpen 2 monthsChecked open todayPosted 2 months ago

Beeline Medicines · United States
$181k–$235k/yrHybrid
StrongChecked open todayPosted 9 days ago
Rhythm Pharmaceuticals · Boston, MA
$160k–$240k/yrFull-timeHybrid
StrongChecked open todayPosted 21 days ago